Lung cancer (LC) continues to pose a significant global medical burden, necessitating a
comprehensive understanding of its molecular foundations to establish effective treatment …

Lung cancer is a leading cause of cancer mortality worldwide. In tumors, the important role
of noncoding RNA regulatory networks has been more and more reveal. EGFR has been …

Nearly half of all Asian non-small cell lung cancer (NSCLC) patients harbour epidermal
growth factor receptor (EGFR) mutations, and first-generation EGFR tyrosine kinase …

Long noncoding RNAs (lncRNA) are a novel class of transcripts with no protein coding
capacity, but with diverse functions in cancer cell proliferation, apoptosis, and metastasis …

Chemotherapy is one of the basic treatments for cancers; however, drug resistance is mainly
responsible for the failure of clinical treatment. The mechanism of drug resistance is …

Long noncoding RNAs (lncRNAs), which refer to a group of RNAs with length more than 200
nucleotides and limited protein-coding potential, play a widespread role in regulating …

The pivotal role of the long non-coding RNA (lncRNA) urothelial carcinoma associated 1
(UCA1) in anti-cancer drug resistance has been confirmed in many cancers. Overexpression …

The aim of this study was to explore the role of long non-coding RNA UCA1 (urothelial
cancer-associated 1) in acquired resistance to epidermal growth factor receptor tyrosine …

Introduction Lung cancer is a major public health problem, as the second causes of cancer
related death worldwide, with relatively low survival rates, and accessible drug resistance …

Abstract Background Long non-coding RNAs (lncRNAs), which are a portion of non-protein-
coding RNAs (ncRNAs), have manifested a paramount role in the pathophysiology of human …